A full scale comparative study of methods for generation of functional Dendritic cells for use as cancer vaccines
Open Access
- 3 July 2007
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 7 (1) , 119
Abstract
Dendritic cells (DCs) are professional antigen-presenting cells with the ability to induce primary T-cell responses and are commonly produced by culturing monocytes in the presence of IL-4 and GM-CSF for 5–7 days (Standard DC). Recently, Dauer and co-workers presented a modified protocol for differentiation of human monocytes into mature DCs within 48 hours (Fast DC). Here we report a functional comparison of the two strategies for generation of DCs from human monocytes with adaptions for large-scale clinical use.Keywords
This publication has 20 references indexed in Scilit:
- IFN-α promotes definitive maturation of dendritic cells generated by short-term culture of monocytes with GM-CSF and IL-4Journal of Leukocyte Biology, 2006
- Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNACancer Gene Therapy, 2006
- Preclinical evaluation of autologous dendritic cells transfected with mRNA or loaded with apoptotic cells for immunotherapy of high-risk neuroblastomaCancer Gene Therapy, 2005
- Preclinical full-scale evaluation of dendritic cells transfected with autologous tumor-mRNA for melanoma vaccinationCancer Gene Therapy, 2005
- A Protocol for Generation of Clinical Grade mRNA‐Transfected Monocyte‐Derived Dendritic Cells for Cancer VaccinesScandinavian Journal of Immunology, 2003
- Dendritic Cell Culture: A Simple Closed Culture System Using Ficoll, Monocytes, and a Table-Top CentrifugeJournal of Hematotherapy & Stem Cell Research, 2003
- Development of a new protocol for 2-day generation of mature dendritic cells from human monocytesBiological Procedures Online, 2003
- mRNA-based electrotransfection of human dendritic cells and induction of cytotoxic T lymphocyte responses against the telomerase catalytic subunit (hTERT)Journal of Immunological Methods, 2002
- Proliferating dendritic cell progenitors in human blood.Journal of Experimental Medicine, 1994
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.Journal of Experimental Medicine, 1994